Direct Rx lidocaine ointment recalled for subpotent drug strength
Direct Rx is recalling 493 jars of Lidocaine Ointment USP, 5.0%, 50g, because the product may contain less lidocaine than its label states. The affected lots are 03AP2511, 30AP2518, 18JU2519, and 18JU2520, with an expiration date of 04/30/2027. The product was distributed nationwide, and no injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check the lot number on the jar against the affected lots listed above.
- If your jar matches, ask your pharmacist or doctor about a replacement before you stop using it.
- Contact Direct Rx with questions about the recall.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
- Sold in
- Nationwide
- Made for
- Adults (under 0 months)
Details
- Units affected
- 493 jars
- Illnesses reported
- None reported
- Manufactured in
- 94 Worldwide Dr, Dawsonville, Georgia, United States
- Classification
- Class II
- Recall number
- D-0107-2027
In the FDA's words
- Description
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50 Subpotent Drug LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027. Distribution: Nationwide within the United States Affected quantity: 493 jars
- Hazard
- Subpotent Drug